Published in Blood on March 07, 2008
Regulation of cellular iron metabolism. Biochem J (2011) 3.03
Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet (2014) 2.70
β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood (2011) 1.81
Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia. Blood (2008) 1.72
Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood (2009) 1.55
Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling. Blood (2014) 1.50
Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev (2013) 1.47
Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. Blood (2008) 1.43
Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. Am J Kidney Dis (2010) 1.43
Iron homeostasis and the inflammatory response. Annu Rev Nutr (2010) 1.40
Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. J Clin Invest (2012) 1.35
Ineffective erythropoiesis and thalassemias. Curr Opin Hematol (2009) 1.34
Anaemia in inflammatory rheumatic diseases. Nat Rev Rheumatol (2012) 1.33
Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1. Blood (2008) 1.31
Iron Loading and Overloading due to Ineffective Erythropoiesis. Adv Hematol (2010) 1.19
Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia. J Am Soc Nephrol (2015) 1.16
ER stress-inducible factor CHOP affects the expression of hepcidin by modulating C/EBPalpha activity. PLoS One (2009) 1.13
Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis. Haematologica (2011) 1.13
Evidence for a lack of a direct transcriptional suppression of the iron regulatory peptide hepcidin by hypoxia-inducible factors. PLoS One (2009) 1.10
Hepcidin modulation in human diseases: from research to clinic. World J Gastroenterol (2009) 1.09
Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis. J Biol Chem (2010) 1.08
Intestinal hypoxia-inducible factor-2alpha (HIF-2alpha) is critical for efficient erythropoiesis. J Biol Chem (2011) 1.03
Expression of growth differentiation factor 15 is not elevated in individuals with iron deficiency secondary to volunteer blood donation. Transfusion (2010) 1.01
Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells. J Virol (2010) 1.00
Erythropoiesis and iron sulfur cluster biogenesis. Adv Hematol (2010) 0.99
Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo. Haematologica (2011) 0.99
Regulation of iron absorption in hemoglobinopathies. Curr Mol Med (2008) 0.97
Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling. Am J Physiol Cell Physiol (2011) 0.95
Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clin Exp Med (2010) 0.95
Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression. Blood (2011) 0.94
Activated macrophages induce hepcidin expression in HuH7 hepatoma cells. Haematologica (2009) 0.92
Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease. World J Nephrol (2012) 0.92
Iron metabolism: current facts and future directions. Biochem Med (Zagreb) (2012) 0.92
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients. Clin J Am Soc Nephrol (2009) 0.92
Low hepcidin levels in severely anemic malawian children with high incidence of infectious diseases and bone marrow iron deficiency. PLoS One (2013) 0.90
Future alternative therapies for β-thalassemia. Expert Rev Hematol (2009) 0.89
Hepcidin messenger RNA expression in human lymphocytes. Immunology (2010) 0.88
Hereditary hemochromatosis in the post-HFE era. Hepatology (2008) 0.87
Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly. Am J Physiol Regul Integr Comp Physiol (2014) 0.86
Function of the hemochromatosis protein HFE: Lessons from animal models. World J Gastroenterol (2008) 0.85
The hypoxia-inducible factor-C/EBPα axis controls ethanol-mediated hepcidin repression. Mol Cell Biol (2012) 0.85
Iron homeostasis in the liver. Compr Physiol (2013) 0.84
Hypoxia-inducible factors link iron homeostasis and erythropoiesis. Gastroenterology (2013) 0.84
Bmp6 expression can be regulated independently of liver iron in mice. PLoS One (2014) 0.82
Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers. Eur J Appl Physiol (2011) 0.82
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis. BMC Nephrol (2013) 0.82
Non-transferrin-bound iron (NTBI) uptake by T lymphocytes: evidence for the selective acquisition of oligomeric ferric citrate species. PLoS One (2013) 0.81
Ferroportin and erythroid cells: an update. Adv Hematol (2010) 0.81
ER Stress and Iron Homeostasis: A New Frontier for the UPR. Biochem Res Int (2010) 0.80
Hepcidin and sports anemia. Cell Biosci (2014) 0.80
Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions. Leuk Res (2014) 0.80
Hepcidin-Dependent Regulation of Erythropoiesis during Anemia in a Teleost Fish, Dicentrarchus labrax. PLoS One (2016) 0.80
Regulation of Hepcidin-25 by Short- and Long-Acting rhEPO May Be Dependent on Ferritin and Predict the Response to rhEPO in Hemodialysis Patients. Nephron Extra (2014) 0.79
Modulation of hepcidin to treat iron deregulation: potential clinical applications. Expert Rev Hematol (2015) 0.79
Duodenal cytochrome b (Cybrd 1) and HIF-2α expression during acute hypoxic exposure in mice. Eur J Nutr (2011) 0.79
Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease. J Cell Mol Med (2014) 0.78
No evidence for protective erythropoietin alpha signalling in rat hepatocytes. BMC Gastroenterol (2009) 0.77
Polysaccharide isolated from Angelica sinensis inhibits hepcidin expression in rats with iron deficiency anemia. J Med Food (2012) 0.77
Laboratory use of hepcidin in renal transplant recipients. Biochem Med (Zagreb) (2016) 0.76
The Regulation of Iron Absorption and Homeostasis. Clin Biochem Rev (2016) 0.76
New perspectives on the molecular basis of the interaction between oxygen homeostasis and iron metabolism. Hypoxia (Auckl) (2015) 0.75
Decreased serum prohepcidin concentration in patients with polycythemia vera. J Zhejiang Univ Sci B (2009) 0.75
Effect of erythropoietin on hepatic cytochrome P450 expression and function in an adenine-fed rat model of chronic kidney disease. Br J Pharmacol (2014) 0.75
Hepcidin and Its Role in Iron Homeostasis. EJIFCC (2009) 0.75
Expression and functional significance of the erythropoietin receptor in hepatocellular carcinoma. HPB (Oxford) (2013) 0.75
Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells. BMC Cancer (2016) 0.75
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science (2004) 19.19
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest (2004) 11.05
CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev (1992) 7.66
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med (2007) 5.18
Regulation of iron metabolism by hepcidin. Annu Rev Nutr (2006) 3.96
Regulators of iron balance in humans. Blood (1994) 3.67
Suppression of hepcidin during anemia requires erythropoietic activity. Blood (2006) 3.32
Isolation and use of liver cells. Methods Enzymol (1978) 3.06
Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem (2006) 2.90
Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood (2007) 2.51
C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem (2002) 2.16
Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology (2007) 2.09
Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis (2003) 1.92
Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood (2003) 1.84
Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis (2003) 1.54
Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell-line HepG2 induced by thalassaemic sera. Br J Haematol (2006) 1.31
Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci (2004) 1.27
The erythropoietin receptor and its expression in tumor cells and other tissues. Oncologist (2004) 1.23
Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol (1992) 1.23
C/EBPalpha is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes. Mol Cell Biol (2004) 1.21
Regulation of erythropoietin production. Eur J Clin Invest (2005) 1.20
ROS mediate the hypoxic repression of the hepcidin gene by inhibiting C/EBPalpha and STAT-3. Biochem Biophys Res Commun (2007) 1.18
Lithium stabilizes the CCAAT/enhancer-binding protein alpha (C/EBPalpha) through a glycogen synthase kinase 3 (GSK3)-independent pathway involving direct inhibition of proteasomal activity. J Biol Chem (2003) 1.09
Organ distribution of erythropoietin messenger RNA in normal and uremic rats. Kidney Int (1991) 1.07
PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors. BMC Biol (2004) 1.04
Re-expression of C/EBP alpha induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells. FEBS Lett (1998) 1.01
Regulation of hepcidin in HepG2 and RINm5F cells. Peptides (2007) 1.00
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors. Am J Physiol Renal Physiol (2006) 0.96
Regulated expression and functional role of the transcription factor CHOP (GADD153) in erythroid growth and differentiation. Blood (1999) 0.95
Identification of the promoter of the mouse obese gene. Proc Natl Acad Sci U S A (1996) 0.91
Insulin-like growth factor (IGF)-II regulates CCAAT/enhancer binding protein alpha expression via phosphatidyl-inositol 3 kinase in human hepatoblastoma cell lines. J Cell Biochem (2007) 0.90
Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes. Arch Toxicol (2001) 0.85
Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes. Int J Biochem Cell Biol (2007) 0.84
Effects of recombinant human erythropoietin on haemolytic anaemia in mice. Br J Haematol (1990) 0.83
A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo. Neuron (2012) 2.72
EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting. Cell (2010) 2.54
Experimental conversion of liver to pancreas. Curr Biol (2003) 2.24
Two novel mutations in the tmprss6 gene associated with iron-refractory iron-deficiency anaemia (irida) and partial expression in the heterozygous form. Br J Haematol (2012) 2.08
Toxicity of amphetamines: an update. Arch Toxicol (2012) 2.00
Beta cells occur naturally in extrahepatic bile ducts of mice. J Cell Sci (2006) 1.58
Isolation and culture of adult mouse hepatocytes. Methods Mol Biol (2010) 1.43
Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol (2009) 1.42
The soluble transferrin receptor as a marker of iron homeostasis in normal subjects and in HFE-related hemochromatosis. Haematologica (2005) 1.40
Conversion of columnar to stratified squamous epithelium in the developing mouse oesophagus. Dev Biol (2005) 1.36
A novel chemically directed route for the generation of definitive endoderm from human embryonic stem cells based on inhibition of GSK-3. J Cell Sci (2011) 1.30
Liver zonation occurs through a beta-catenin-dependent, c-Myc-independent mechanism. Gastroenterology (2009) 1.25
In vitro transdifferentiation of hepatoma cells into functional pancreatic cells. Mech Dev (2005) 1.23
Antioxidative properties of cardoon (Cynara cardunculus L.) infusion against superoxide radical, hydroxyl radical, and hypochlorous acid. J Agric Food Chem (2002) 1.22
Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo. PLoS Genet (2010) 1.16
ER stress-inducible factor CHOP affects the expression of hepcidin by modulating C/EBPalpha activity. PLoS One (2009) 1.13
Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formation. J Clin Invest (2008) 1.11
Studies on the antioxidant activity of Lippia citriodora infusion: scavenging effect on superoxide radical, hydroxyl radical and hypochlorous acid. Biol Pharm Bull (2002) 1.11
Khat and synthetic cathinones: a review. Arch Toxicol (2013) 1.08
Connexins protect mouse pancreatic β cells against apoptosis. J Clin Invest (2011) 1.08
Profiling of RNA degradation for estimation of post morterm interval. PLoS One (2013) 1.07
Transdifferentiation, metaplasia and tissue regeneration. Organogenesis (2004) 1.02
The molecular basis of transdifferentiation. J Cell Mol Med (2005) 1.01
Transdifferentiation in developmental biology, disease, and in therapy. Dev Dyn (2007) 1.00
Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation. Blood (2002) 0.98
Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats. Toxicology (2006) 0.98
Transdifferentiation of pancreas to liver. Mech Dev (2003) 0.98
Isolation and activation of human neutrophils in vitro. The importance of the anticoagulant used during blood collection. Clin Biochem (2008) 0.98
How does inflammation cause Barrett's metaplasia? Curr Opin Pharmacol (2009) 0.96
Glucocorticoids suppress beta-cell development and induce hepatic metaplasia in embryonic pancreas. Biochem J (2003) 0.95
The CD8+ T-lymphocyte profile as a modifier of iron overload in HFE hemochromatosis: an update of clinical and immunological data from 70 C282Y homozygous subjects. Blood Cells Mol Dis (2006) 0.94
Green tea averts age-dependent decline of hippocampal signaling systems related to antioxidant defenses and survival. Free Radic Biol Med (2010) 0.94
Hepatic differentiation of murine embryonic stem cells. Exp Cell Res (2002) 0.94
A study of 82 extended HLA haplotypes in HFE-C282Y homozygous hemochromatosis subjects: relationship to the genetic control of CD8+ T-lymphocyte numbers and severity of iron overload. BMC Med Genet (2006) 0.93
Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature. Arch Toxicol (2002) 0.93
Induction and regulation of acute phase proteins in transdifferentiated hepatocytes. Exp Cell Res (2004) 0.93
Protective effect of an ERAP1 haplotype in ankylosing spondylitis: investigating non-MHC genes in HLA-B27-positive individuals. Rheumatology (Oxford) (2013) 0.92
Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells. Arch Toxicol (2002) 0.92
Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons. Neurotoxicology (2007) 0.92
Postmortem analyses unveil the poor efficacy of decontamination, anti-inflammatory and immunosuppressive therapies in paraquat human intoxications. PLoS One (2009) 0.92
A rapid and simple procedure for the establishment of human normal and cancer renal primary cell cultures from surgical specimens. PLoS One (2011) 0.92
In vitro culture of embryonic mouse intestinal epithelium: cell differentiation and introduction of reporter genes. BMC Dev Biol (2006) 0.91
[Paraquat intoxication and hemocarboperfusion]. Acta Med Port (2006) 0.90
Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human. Toxicology (2005) 0.90
Keratinocyte serum-free medium maintains long-term liver gene expression and function in cultured rat hepatocytes by preventing the loss of liver-enriched transcription factors. Int J Biochem Cell Biol (2006) 0.89
A new 500 kb haplotype associated with high CD8+ T-lymphocyte numbers predicts a less severe expression of hereditary hemochromatosis. BMC Med Genet (2008) 0.89
Role of superoxide and hydrogen peroxide in hypertension induced by an antagonist of adenosine receptors. Eur J Pharmacol (2008) 0.89
Strengthening the perception-assessment tools for dengue prevention: a cross-sectional survey in a temperate region (Madeira, Portugal). BMC Public Health (2014) 0.88
Hepcidin messenger RNA expression in human lymphocytes. Immunology (2010) 0.88
Stem cells in the adult pancreas and liver. Biochem J (2007) 0.88
Oxidation process of adrenaline in freshly isolated rat cardiomyocytes: formation of adrenochrome, quinoproteins, and GSH adduct. Chem Res Toxicol (2007) 0.88
Mechanisms of cholinesterase inhibition by inorganic mercury. FEBS J (2007) 0.88
Cocaine-induced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cells. Arch Toxicol (2011) 0.88
The Wnt/beta-catenin pathway: master regulator of liver zonation? Bioessays (2006) 0.87
Kidney and anemia in familial amyloidosis type I. Kidney Int (2004) 0.87
Dexamethasone treatment induces the reprogramming of pancreatic acinar cells to hepatocytes and ductal cells. PLoS One (2010) 0.87
Flavonoids with an oligopolysulfated moiety: a new class of anticoagulant agents. J Med Chem (2010) 0.87
Co-selection of the H63D mutation and the HLA-A29 allele: a new paradigm of linkage disequilibrium? Immunogenetics (2002) 0.87
Low serum transferrin levels in HFE C282Y homozygous subjects are associated with low CD8(+) T lymphocyte numbers. Blood Cells Mol Dis (2005) 0.86
Differential Effects of Methyl-4-Phenylpyridinium Ion, Rotenone, and Paraquat on Differentiated SH-SY5Y Cells. J Toxicol (2013) 0.86
Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A. Addict Biol (2008) 0.86
Human cardiac tissue induces transdifferentiation of adult stem cells towards cardiomyocytes. Cytotherapy (2010) 0.86
Characterization of liver function in transdifferentiated hepatocytes. J Cell Physiol (2006) 0.86
Neurotoxicity of "ecstasy" and its metabolites in human dopaminergic differentiated SH-SY5Y cells. Toxicol Lett (2012) 0.86
Therapeutic potential of transdifferentiated cells. Clin Sci (Lond) (2005) 0.85
The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine. Toxicology (2004) 0.85
Comparative study between Hfe-/- and beta2m-/- mice: progression with age of iron status and liver pathology. Int J Exp Pathol (2006) 0.85
Differentiation of pancreatic acinar cells to hepatocytes requires an intermediate cell type. Gastroenterology (2010) 0.85
Nickel induces oxidative burst, NF-κB activation and interleukin-8 production in human neutrophils. J Biol Inorg Chem (2010) 0.84
Polysulfated xanthones: multipathway development of a new generation of dual anticoagulant/antiplatelet agents. J Med Chem (2011) 0.84
Structural isomerization of synephrine influences its uptake and ensuing glutathione depletion in rat-isolated cardiomyocytes. Arch Toxicol (2010) 0.84
Mechanisms underlying the hepatotoxic effects of ecstasy. Curr Pharm Biotechnol (2010) 0.84
Isolation and culture of embryonic pancreas and liver. Methods Mol Biol (2010) 0.84
Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes. Toxicology (2009) 0.84
Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates. Arch Toxicol (2003) 0.84
Monoamine oxidase-B mediates ecstasy-induced neurotoxic effects to adolescent rat brain mitochondria. J Neurosci (2007) 0.84
Chronic exposure to ethanol exacerbates MDMA-induced hyperthermia and exposes liver to severe MDMA-induced toxicity in CD1 mice. Toxicology (2008) 0.84
Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro. Chem Res Toxicol (2004) 0.84
Protective activity of hesperidin and lipoic acid against sodium arsenite acute toxicity in mice. Toxicol Pathol (2004) 0.83
Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones. Arch Toxicol (2014) 0.83
Improvement of genetic stability in lymphocytes from Fanconi anemia patients through the combined effect of α-lipoic acid and N-acetylcysteine. Orphanet J Rare Dis (2012) 0.83
All-trans retinoic acid suppresses exocrine differentiation and branching morphogenesis in the embryonic pancreas. Differentiation (2007) 0.83
Cdx genes, inflammation and the pathogenesis of Barrett's metaplasia. Trends Mol Med (2009) 0.83
In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells. Arch Toxicol (2010) 0.83
Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin. Toxicol Lett (2013) 0.82
The intercellular synchronization of Ca2+ oscillations evaluates Cx36-dependent coupling. PLoS One (2012) 0.82
Liver specification: a new role for Wnts in liver development. Curr Biol (2006) 0.82
Xanthine oxidoreductase is present in bile ducts of normal and cirrhotic liver. Free Radic Biol Med (2004) 0.82
Chronic green tea consumption prevents age-related changes in rat hippocampal formation. Neurobiol Aging (2009) 0.82
Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia. J Pharmacol Exp Ther (2005) 0.82
Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine ('Ecstasy') cytotoxicity. Pharmacogenet Genomics (2006) 0.82
Streptozotocin-induced diabetes modulates action potentials and ion channel currents from the rat atrioventricular node. Exp Physiol (2009) 0.82
C/EBPalpha and C/EBPbeta are markers of early liver development. Int J Dev Biol (2006) 0.82
Molecular aspects of esophageal development. Ann N Y Acad Sci (2011) 0.81